Morningstar Investor users sign in here.

Company Profile

  • Business description

    bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

  • Contact

    455 Grand Union Boulevard
    Somerville MA 02145
    USA

    T: +1 339 499-9300

    E: IGoldberg@bluebirdbio.com

    https://www.bluebirdbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    323

Stocks News & Analysis

video

Impact of the supermarkets code of conduct

Morningstar Director of Equity Research Johannes Faul explains the impact of the political hot water that Coles and Woolworths face. 
stocks

Four cheap wide moat ASX stocks

We follow Buffett’s adage to find great companies trading at attractive prices. 
stocks

5 top US dividend shares from the best managers

These cheap dividend stocks are popular among highly rated concentrated fund managers.

Market Movers

Name
Last price
Change
% Change
Sayona Mining Ltd SYA 0.04 0.00 0.00%
The Star Entertainment Group Ltd SGR 0.42 0.00 0.00%
Zip Co Ltd ZIP 1.18 0.01 -0.84%
Renascor Resources Ltd RNU 0.11 0.02 26.51%
Imugene Ltd IMU 0.08 0.00 0.00%
Strickland Metals Ltd STK 0.14 0.02 12.50%
Droneshield Ltd DRO 1.12 0.18 18.52%
Telstra Group Ltd TLS 3.68 0.00 0.00%
Red 5 Ltd RED 0.43 0.01 1.18%
Evolution Mining Ltd EVN 4.16 0.29 7.49%